£7.6 million Nottingham care home adds to Target Healthcare portfolio


Target Healthcare (LSE: THRL), the UK’s listed specialist investor in modern, purpose-built care homes, announces that it has completed the acquisition of a property in the city of Nottingham for approximately £7.6 million, including transaction costs, through a sale and leaseback.

Constructed in 2013, Acorn House comprises 64 bedrooms, each with full en suite wetroom facilities, over three floors.  It is close to the centre of Nottingham in a densely-populated area where the Group’s research has shown there is a strong demand for this type of modern home, of which there is low supply.

The investment fully meets the Group’s strict criteria, including being recently purpose built with modern facilities and high quality of care provision, and is backed by a strong trading history with consistently high occupancy providing strong rent cover.

The home has been operated since opening by Acacia Care, a local operator which has three homes, another of which is already owned by Target Healthcare.  They have plans to grow further over the coming years.  The home has been leased back to them on a 35-year lease with an RPI-linked cap and collar.  The yield on acquisition is consistent with the overall yield in the THRL portfolio and, as the home is already trading, there is no rent-free period.

John Flannelly, Head of Investment at Target Fund Managers, commented:

“This acquisition brings the number of assets in our portfolio to 63 including developments and offers us the opportunity to support the growth of a tenant we regard as an operator of quality.  The home has positive CQC ratings and provides a warm and welcoming environment for its residents.

“In addition to this investment, we have recently seen three forward fund developments in our portfolio open to residents.  The care home market is undersupplied with the quality of asset which we provide, while demand is growing apace, underpinning our conviction in the portfolio we are assembling.”


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.